J&J’s announcement didn’t include any details of why Mammen had decided to leave the company.
Johnson & Johnson’s head of R&D is off. In a surprise post-market announcement yesterday, the company revealed that its executive vice president of pharma R&D Mathai Mammen, M.D., Ph.D, is leaving to “pursue other opportunities.”
In a LinkedIn post in January, Mammen said he had a “very good feeling about 2022” and drew attention to how J&J was harnessing data science to “help decide where we focus, invent a therapeutic or vaccine, and develop the right evidence sets targeting the right people.” However, this positive outlook was apparently not enough to keep him at the Big Pharma for the long term.
In fairness to J&J... Randomised clinical trials of COVID-19 vaccines: do adenovirus-vector vaccines have beneficial non-specific effects? Potential differences in the effects of adenovirus-vector and mRNA vaccines on overall mortality, if true, could have a major impact on global health. If validated in additional studies, the protective heterologous effects of adenovirus-based vaccines on non-COVID-19 mortality, in addition to their effectiveness against SARS-CoV-2 infection, may represent an important advantage in vulnerable populations in which cardiovascular mortality is important.
Wasn't the J&J vax the first to be pulled for causing blood clots?
When I first heard that the mRNA virus worked by causing your bodies cells to create part of a virus so that the bodies antibodies could be triggered to fight the product of these mutated cells, I was out. A little research reinforced my suspicions about the potential dangers of this vax. I vowed to lose my job rather than be forced to take this experimental biologic agent.
Up about 40% if I recall from the last insurance article I read.
There are the immediate deaths within a week or two, and that drops off quickly, but then there are quite a few sudden deaths months or more than a year after the jab. And given that the jab suppresses immunity, people also die of a wide variety of things that happen when your immune system is suppressed, like cancers.
I bet all-cause mortality will continue to rise for years because of the mass vaxxing.
My friend took one jab of this and has been fully disabled since with horrible pain and disorientation, as well as other nervous system dysfunction. She’s wheelchair bound now. This jab is not safe!
Johnson & Johnson’s head of R&D is off. In a surprise post-market announcement yesterday, the company revealed that its executive vice president of pharma R&D Mathai Mammen, M.D., Ph.D, is leaving to “pursue other opportunities.”
In a LinkedIn post in January, Mammen said he had a “very good feeling about 2022” and drew attention to how J&J was harnessing data science to “help decide where we focus, invent a therapeutic or vaccine, and develop the right evidence sets targeting the right people.” However, this positive outlook was apparently not enough to keep him at the Big Pharma for the long term.
https://www.fiercebiotech.com/biotech/jjs-head-rd-mathai-mammen-heads-exit-surprise-move